Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cannabics Pharmaceuticals Inc (CNBX)

Cannabics Pharmaceuticals Inc (CNBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
Trade CNBX with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1500 +3.40%
on 09/14/21
0.1806 -14.12%
on 08/31/21
-0.0049 (-3.06%)
since 08/17/21
3-Month
0.1500 +3.40%
on 09/14/21
0.2000 -22.45%
on 06/21/21
-0.0347 (-18.28%)
since 06/17/21
52-Week
0.1350 +14.89%
on 10/13/20
0.6000 -74.15%
on 02/10/21
-0.0165 (-9.62%)
since 09/17/20

Most Recent Stories

More News
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine

Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and a pioneer in the development...

CNBX : 0.1551 (-0.64%)
Hemato-Oncology Expert, Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals' Board of Advisors

Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Dr. (MD),...

CNBX : 0.1551 (-0.64%)
World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors

Israel and BETHESDA, Maryland, /PRNewswire/ --  (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Prof. (MD. Ph.D.), a world-renowned...

CNBX : 0.1551 (-0.64%)
Cannabics Pharmaceuticals Appoints a Second Independent Board Member

Israel and BETHESDA, Maryland, /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it...

CNBX : 0.1551 (-0.64%)
Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member

Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has...

CNBX : 0.1551 (-0.64%)
Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice

Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, released today the interim results...

CNBX : 0.1551 (-0.64%)
Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases

Israel and BETHESDA, Maryland, /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the expansion...

CNBX : 0.1551 (-0.64%)
Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program

, Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching...

CNBX : 0.1551 (-0.64%)
The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology

, Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the company's...

CNBX : 0.1551 (-0.64%)
Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment Formulations

, Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it had...

CNBX : 0.1551 (-0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.1698
2nd Resistance Point 0.1649
1st Resistance Point 0.1600
Last Price 0.1551
1st Support Level 0.1502
2nd Support Level 0.1453
3rd Support Level 0.1404

See More

52-Week High 0.6000
Fibonacci 61.8% 0.4224
Fibonacci 50% 0.3675
Fibonacci 38.2% 0.3126
Last Price 0.1551
52-Week Low 0.1350

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar